Fabry disease causes a wide range of symptoms that typically start in childhood and worsen over time. Because a fatty substance called Gb3 builds up inside cells throughout the body, almost every organ system can eventually be affected. The earliest and most recognizable symptom is intense burning pain in the hands and feet, which can appear as young as age 2 in boys. From there, symptoms expand to include skin changes, kidney damage, heart problems, and an elevated risk of stroke.
Because Fabry disease is rare and its symptoms overlap with many common conditions, the average patient waits years before receiving a correct diagnosis. Knowing the full picture of what this disease looks like, from early childhood through adulthood, can help you or your doctor connect the dots sooner.
Burning Pain in the Hands and Feet
The hallmark early symptom is severe, episodic burning pain in the hands and feet, a condition called acroparesthesia. In boys with the classic form, this pain can begin between ages 2 and 8. Girls who carry the gene may develop it during childhood or adolescence, though often later and with less intensity. The pain is frequently triggered by exercise, fatigue, emotional stress, fever, or warm temperatures. Some children describe it as a tingling or “pins and needles” sensation that flares into a deep burn. These episodes can last minutes to days and are sometimes intense enough to keep a child home from school.
Reduced Sweating and Heat Intolerance
Many people with Fabry disease produce little to no sweat. This happens because the buildup of Gb3 damages the small nerve fibers that control the sweat glands. Without the ability to sweat normally, the body struggles to cool itself. You might notice that your socks are never damp at the end of the day, or that exercise in warm weather causes exhaustion, nausea, and a racing heart but no sweating. This reduced sweating makes hot environments genuinely dangerous and is one reason physical activity triggers pain flares. It also contributes to chronically dry skin.
Skin Spots Called Angiokeratomas
Small, dark red or purple raised spots commonly appear on the skin, clustered in a pattern doctors sometimes describe as “bathing trunk” distribution. That means they concentrate between the waist and mid-thigh: the flanks, buttocks, inner thighs, and genital area. They can also show up around the belly button, near the mouth, or on the palms. These spots are tiny dilated blood vessels near the skin’s surface with a slightly rough or scaly texture. They’re painless and don’t usually cause medical problems on their own, but their distinctive pattern is a strong visual clue for diagnosis. In women, the spots tend to be fewer and more scattered.
Digestive Problems
Fabry disease frequently causes gastrointestinal symptoms that are easy to mistake for irritable bowel syndrome or food intolerances. Cramping abdominal pain, diarrhea, nausea, and bloating are common, particularly after eating. These symptoms result from Gb3 deposits in the blood vessels and nerves of the gut. Because they’re so nonspecific, digestive complaints in Fabry patients are among the most commonly misdiagnosed symptoms, sometimes for a decade or more before the underlying cause is identified.
Kidney Damage
The kidneys are one of the organs most seriously affected by Fabry disease. Gb3 accumulates in kidney cells over years, gradually impairing their ability to filter blood. The earliest detectable sign is excess protein spilling into the urine. Left untreated, kidney function declines steadily, and kidney failure is one of the most common life-threatening complications. This progression is typically silent in its early stages. You won’t feel kidney damage happening, which is why routine urine and blood tests are critical for anyone diagnosed with or suspected of having the disease.
Heart Complications
Gb3 deposits gradually thicken the walls of the heart, particularly the left ventricle, the chamber responsible for pumping blood to the rest of the body. This thickening, known as left ventricular hypertrophy, is the most common cardiac finding. The right ventricle is often affected too. Other cardiovascular manifestations include heart valve abnormalities (especially leaking of the aortic and mitral valves), irregular heart rhythms, coronary artery disease, and high blood pressure.
Many patients with early heart involvement have no symptoms at all. As the disease progresses, some develop chest pain, shortness of breath, palpitations, or fainting spells. In advanced cases, heart failure can develop even when the heart’s pumping strength appears normal on imaging, a confusing finding that sometimes delays the correct diagnosis.
Stroke Risk
Fabry disease significantly raises the risk of stroke, often at an unusually young age. Data from the Fabry Registry found that about 7% of males and 4% of females experienced a stroke, with nearly 22% of those strokes occurring before age 30. Two patients had strokes during their teenage years. Stroke risk climbs sharply for men over 45. Patients who had strokes were also far more likely to have experienced warning signs beforehand: 36% had a history of transient ischemic attacks (brief stroke-like episodes), compared to just 5% of Fabry patients without stroke. Notably, stroke frequently occurs before Fabry disease has even been diagnosed.
Eye Changes
One of the most distinctive findings in Fabry disease appears in the eyes, though you won’t see it in the mirror. A whorl-like pattern of deposits forms on the surface of the cornea, visible only during a specialized eye exam with a slit lamp. The pattern develops as deposit-laden cells migrate inward from the edge of the cornea during normal tissue repair, creating a spiral or pinwheel appearance. This corneal finding is extremely common in Fabry patients and is sometimes the clue that first leads an ophthalmologist to suspect the disease. It generally does not cause significant vision loss on its own, though some patients report decreased vision over time from other eye-related complications.
How Symptoms Differ in Women
Fabry disease is caused by a mutation on the X chromosome. Because males have only one X chromosome, a single copy of the faulty gene leads to the full classic disease. Females have two X chromosomes, and in each cell, one is randomly switched off, a process called X-inactivation. This means women with Fabry disease have a mosaic of affected and unaffected cells, and the ratio varies from person to person.
The practical result is enormous variability. Some women have symptoms nearly as severe as men, while others remain mildly affected or even asymptomatic well into adulthood. Pain, skin spots, and digestive symptoms tend to appear later and with less intensity. However, women are not spared from serious organ damage. Kidney disease, heart complications, and stroke all occur in female patients, sometimes progressing without the earlier warning signs that prompt diagnosis in men. For this reason, Fabry disease in women is frequently underdiagnosed or dismissed as a “carrier” state when active monitoring and treatment may actually be needed.
How Symptoms Progress Over Time
Fabry disease is progressive. In childhood, the dominant symptoms are pain, heat intolerance, reduced sweating, and digestive issues. Skin spots often appear during adolescence or early adulthood. Kidney and heart involvement typically become measurable in the late teens to thirties, though damage is accumulating silently before that. By the fourth and fifth decades, organ complications dominate the clinical picture: worsening kidney function, thickening of the heart, and rising stroke risk. Without treatment, life expectancy in men with classic Fabry disease is shortened by roughly 20 years compared to the general population. Women face a reduced but still significant impact on lifespan.
A blood test measuring a specific biomarker (a fatty molecule that accumulates when the disease is active) can help confirm a diagnosis. Normal levels are below 1.0 ng/mL, and elevations support a Fabry diagnosis. This same marker is used to track disease progression and response to treatment over time, though some patients with milder forms may have normal levels despite having the disease.